Page 205 - CW E-Magazine (3-12-2024)
P. 205

Special Report


       GC  with  estimated prevention of   (3S,5R)-Dihydroxy-6-(benzyloxy)  to the traditional batch processes. The

       80-million gallons of waste.        Hexanoic  Acid, Ethyl Ester for  success of the entire process is credited
                                           Statins (Anticholesterol Drugs);  to the continuous process technologies
          There are many more examples   (S)-2-[3,2[7-Chloro-2-quinolinyl]  facilitated  by  fl ow  chemistry,  analytical

       available  in the literature(3).  These   ethenyl]-phenyl-3 hydroxypropyl]  science and engineering, process
       include synthesis of Artemisinin, Silde-  benzoic  Acid, Methyl Ester for  modelling, and equipment design.
       nafi l  Citrate, Atorvastatin,  Paroxetine,   Montelukast;
       Sitagliptin,  Levetiracetam,  Pregabalin,   The enzymatic preparation of  (R)-  Conclusions

       β-Lactam  Antibiotics,  Aprepitant,   Allylic  Alcohol  for an Integrin   The idea  of GC and its principles
       Imatinib, Paclitaxel, Celecoxib, Clopi-  Receptor Antagonist etc.   have been known  since 1990,  but the
       dogrel Bisulfate, Quinapril,  Valsartan,                           real implementation of these rules in
       LY300164 (a potential  drug majorly  Continuous processing and process   drug designing and synthesis has still
       for the treatment of neurodegenerative  intensifi cation            been limited. But the implication of
       disorders like  Alzheimer’s epilepsy   The idea of Continuous Processing  GC in synthesis in the form of green
       and  Huntingdon’s diseases), ABT-546  and  Process  Intensifi cation  (PI)  has  solvents, alternative reaction media,
       (a potent, highly selective,  and active  attracted the full attention of synthetic  minimizing  waste,  and  retaining  effi -
       endothelin ETA receptor antagonist).  organic  chemists since the  beginning  cacy will always remain in the fore-
                                         of the 21st century.  The reasons are  front. Continuous processing is another
       Green synthesis of starting raw materials  environmental awareness and constant  acceptable approach for swift reaction
          The green synthesis of starting raw  pressure from the legislators to curtail  times, rapid reaction  screening and
       materials can ultimately lead to the  the emissions of synthetic  waste and  optimization, operational protection,
       greenness  of  fi nal APIs  by  maintaining  promote energy effi ciency by adopting  improved automation with feasible in-
       the green chemistry principles from start  greener technologies.   clusion of in-line reaction analysis, and
       to end of the synthesis journey of an API.                         easy scalability to plant scale. Process
                                           Continuous processing is well  intensifi cation offers modernization and
       Some examples include synthesis of:  accepted due to its benefi ts suchas quick  innovation of new hybrid equipment by
         Ketal Ester for  Oseltamivir  reaction times, rapid reaction screening  scrapping  old-age reactions  and units
          Phosphate;                     and  optimization, operational  safety,  for high reactor yield productivity and
          (S)-N-BOC-3-Hydroxyadamantyl-  enhanced automation with feasible in-  eventually high-purity products.
          glycine for Saxagliptin;       clusion of in-line reaction analysis, and
         (S)-tert-Leucine  for Atazanavir,  effortless scalability to the plant scale.  REFERENCES
          Boceprevir, and Telaprevir;    Similarly,  PI  can  offer  modernization  1.  Green Chemistry. U.S. Environ-
         Allysine Ethylene  Acetal for  and invention of new equipment design   mental  Protection  Agency.  https://
          Vanlev, Dihydrodiols  for Indinavir  and processing to enhance process effi -  www.epa.gov/greenchemistry. Up-
          (Crixivan);                    ciency and the development of new-age   dated November 2, 2022. Accessed
          (R)-3-(4-Fluorophenyl)-2-hydroxy  reactors  and hybrid units, as well as   November 22, 2022.
          propionic  scid  for  Rhinovirus  Pro  separation technologies offering high  2.  Desai, M., Njoku,  A., and Nimo-
          tease Inhibitor Rupintrivir (AG7088);  reactor yield productivity and eventu-  Sefah, L. Comparing Environmental
          (R)-Phenylacetyl   Carbinol   for  ally high-purity products.     Policies  to  Reduce  Pharmaceutical
          Ephedrine;                                                         Pollution  and  Address  Disparities.
          (S)-3-(3,4-Dichlorophenyl)-5-   Thus, at times  an old-age  process   International  Journal of Environ-
          ethoxy-5-oxopentanoic Acid for NK1/  can be upgraded through Continuous   mental Research and Public Health.
          NK2 Dual Antagonists;          Processing  and  PI,  without  changing   https://www.ncbi.nlm.nih.gov/pmc/
          Nitroalkanes for  Tamsulosin and  the reaction scheme at all. Eli Lilly pro-  articles/PMC9325029/.  Published
          Selegiline;                    duced around 3-kg of prexasertib mono-  July 7, 2022. Accessed November
          (1S,2R)-[3-Chloro-2-hydroxy-1-  lactate monohydrate per day, employing   22, 2022.
          (phenylmethyl)propyl]-carbamic  small continuous  reactors, extractors,  3.  Kar S., Sanderson H., Roy K., Ben-
          acid, 1,1-Dimethylethyl  Ester for  evaporators, crystallizers, and fi lters in   fenati E., and Leszczynski L., Green
          Atazanavir;                    the  laboratory  fume  hoods.  This con-  Chemistry in the Synthesis of Pharma-
         N-Acetylneuraminic Acid  for  tinuous process allowed  superior per-  ceuticals,  Chem. Rev. 2022, 122,
          Zanamivir (Relenza);           formance  and process safety relative   3637−3710.


       Chemical Weekly  December 3, 2024                                                               205


                                      Contents    Index to Advertisers    Index to Products Advertised
   200   201   202   203   204   205   206   207   208   209   210